Recall Atlas
Drugs & medicalType II

TARO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution

Product quality

Read the official notice →
Date
2026-02-09
Country
Canada
Product
TARO-CANDESARTAN
Classification
Type II
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2026-02-11
  2. CA
    Drugs & medicalType II

    Medline Kits containing Surgical Gowns, Packs and Drapes

    Sterility

    Health CanadaOfficial notice →
  3. 2026-02-10
  4. CA
    Drugs & medicalType II

    Alphenix Systems

    Performance

    Health CanadaOfficial notice →
  5. CA
    Drugs & medicalType II

    VISERA™ Imaging System

    Performance

    Health CanadaOfficial notice →
  6. 2026-02-09
  7. CA
    Drugs & medicalType III

    Cefazolin for Injection: Affected lots are packaged with the incorrect Linear barcode on inner and outer bag labels.

    Labelling

    Health CanadaOfficial notice →
  8. CA
    Drugs & medicalType I

    MAR-AMLODIPINE: affected lots may contain tablet(s) of Midodrine 2.5mg tablets.

    Product safety

    Health CanadaOfficial notice →
  9. 2026-02-07
  10. CA
    Drugs & medical

    Two lots of MAR-Amlodipine 5 mg tablets recalled as some bottles may contain the wrong drug

    Product safety

    Health CanadaOfficial notice →
See all drugs & medical recalls →